BIOMAT Database Logo BIOMAT Database Logo

[Renin-angiotensin-aldosterone system in patients with Itsenko-Cushing syndrome treated with chloditane and large doses of reserpine]. 1980

V N Slavnov, and A A Iakovlev, and I V Komissarenko, and A K Cheban, and S I Rybakov

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008939 Mitotane A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression. o,p-DDD,ortho,para-DDD,Chloditan,Chlodithane,Khloditan,Lysodren,Mytotan,ortho,para DDD
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D012110 Reserpine An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use. Raunervil,Raupasil,Rausedil,Rausedyl,Serpasil,Serpivite,V-Serp,V Serp
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000450 Aldosterone A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

V N Slavnov, and A A Iakovlev, and I V Komissarenko, and A K Cheban, and S I Rybakov
[Glucocorticoid kinetics in Cushing's syndrome treated with chloditane and large doses of reserpine].
January 1981, Problemy endokrinologii,
V N Slavnov, and A A Iakovlev, and I V Komissarenko, and A K Cheban, and S I Rybakov
[Renin-aldosterone in Itsenko-Cushing disease].
January 1977, Terapevticheskii arkhiv,
V N Slavnov, and A A Iakovlev, and I V Komissarenko, and A K Cheban, and S I Rybakov
[Glucocorticoid function of the adrenals in patients with Itsenko-Cushing disease treated with chloditane].
January 1979, Klinicheskaia meditsina,
V N Slavnov, and A A Iakovlev, and I V Komissarenko, and A K Cheban, and S I Rybakov
[Results of treatment of Cushing's syndrome with chloditane and large doses of reserpine].
January 1983, Problemy endokrinologii,
V N Slavnov, and A A Iakovlev, and I V Komissarenko, and A K Cheban, and S I Rybakov
Renin-angiotensin-aldosterone system in nephrotic syndrome.
July 1984, American journal of kidney diseases : the official journal of the National Kidney Foundation,
V N Slavnov, and A A Iakovlev, and I V Komissarenko, and A K Cheban, and S I Rybakov
Prevention and management of hyperkalemia in patients treated with renin-angiotensin-aldosterone system inhibitors.
December 2021, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
V N Slavnov, and A A Iakovlev, and I V Komissarenko, and A K Cheban, and S I Rybakov
Renin-angiotensin system and plasma aldosterone in Cushing's syndrome.
December 1983, Endocrinologia japonica,
V N Slavnov, and A A Iakovlev, and I V Komissarenko, and A K Cheban, and S I Rybakov
[Renin-angiotensin-aldosterone system].
June 2004, Nihon rinsho. Japanese journal of clinical medicine,
V N Slavnov, and A A Iakovlev, and I V Komissarenko, and A K Cheban, and S I Rybakov
Renin-angiotensin-aldosterone system.
July 1980, European journal of clinical pharmacology,
V N Slavnov, and A A Iakovlev, and I V Komissarenko, and A K Cheban, and S I Rybakov
[Renin-angiotensin-aldosterone system].
April 2007, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!